Programmed Death 1 Is Highly Expressed on CD8+CD57+ T Cells in Patients With Stable Multiple Sclerosis and Inhibits Their Cytotoxic Response to EBV

Immunology - United Kingdom
doi 10.1111/imm.12808
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Programmed Death-1 Impairs Secondary Effector Lung CD8+T Cells During Respiratory Virus Reinfection

Journal of Immunology
AllergyImmunology
2014English

Cytotoxic NKG2C+ CD4 T Cells Target Oligodendrocytes in Multiple Sclerosis

Journal of Immunology
AllergyImmunology
2013English

Programmed Cell Death-1 Is Expressed in Large Retinal Ganglion Cells and Is Upregulated After Optic Nerve Crush

Experimental Eye Research
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2015English

Increased Programmed Death-1 Expression on CD4+ T Cells in Cutaneous T-Cell Lymphoma

Archives of Dermatology
2010English

Loss of Circulating CD8+ CD161high T Cells in Primary Progressive Multiple Sclerosis

Frontiers in Immunology
AllergyImmunology
2019English

Patients With Multiple Myeloma Treated With Thalidomide: Evaluation of Clinical Parameters, Cytokines, Angiogenic Markers, Mast Cells and Marrow CD57+ Cytotoxic T Cells as Predictors of Outcome

Haematologica
Hematology
2007English

Programmed Death-Ligand 1 Expression Correlates With Diminished CD8+ T Cell Infiltration and Predicts Poor Prognosis in Anal Squamous Cell Carcinoma Patients

Cancer Management and Research
Oncology
2017English

Early Everolimus Initiation Fails to Counteract the Cytotoxic Response Mediated by CD8+ T and NK Cells in Heart Transplant Patients

Frontiers in Immunology
AllergyImmunology
2018English

Programmed Death-1 Expression on Epstein Barr Virus Specific CD8+ T Cells Varies by Stage of Infection, Epitope Specificity, and T-Cell Receptor Usage

PLoS ONE
Multidisciplinary
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy